References
- ChengTYCrambSMBaadePDYouldenDRNwoguCReidMEThe International epidemiology of lung cancer: latest trends, disparities, and tumor characteristicsJ Thorac Oncol201611101653167127364315
- KawaguchiTKohYAndoMProspective analysis of oncogenic driver mutations and environmental factors: Japan molecular epidemiology for lung cancer studyJ Am Soc Clin Oncol2016341922472257
- MolinaJRYangPCassiviSDSchildSEAdjeiAANon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipMayo Clin Proc200883558459418452692
- DidkowskaJWojciechowskaUMańczukMŁobaszewskiJLung cancer epidemiology: contemporary and future challenges worldwideAnn Transl Med20164815027195268
- HoffmanPCMauerAMVokesEELung cancerLancet2000355920247948510841143
- SarihanSKayisogullariUErcanIEnginKRandomized phase 2 study of radiotherapy alone versus radiotherapy with paclitaxel in non-small cell lung cancerJ Int Med Res200432437538315303768
- SparanoJAJWangMMartinoSWeekly paclitaxel in the adjuvant treatment of breast cancerJ Evid-Based Med20093593310
- FujiiTTachibanaMDharDKCombination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in miceAnticancer Res2003233B2405241112894521
- WuZHLuMKHuLYLiXZhWLyHUPraziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growthPLoS One2012712e5172123251610
- de SouzaRZahediPAllenCJPiquette-MillerMPolymeric drug delivery systems for localized cancer chemotherapyDrug Deliv201017636537520429844
- Mora-HuertasCEFessiHElaissariAPolymer-based nanocapsules for drug deliveryInt J Pharm20103851–211314219825408
- YadavAKAgarwalARaiGDevelopment and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracilDrug Deliv201017856157220738221
- YangBNiXChenLHonokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinomaDrug Deliv201724166066928368206
- XiCChaoLKaijiangLThe research on functional mechanism of timely chemotherapyMod Prev Med2008352201202
- JunquanYLipingLRuijuanZPerlimary results of concurrent three-dimenonal conformal radio therapy combined with Chronochemotrapy for advanced non-small cell lung cancerMod Prev Med200633712831291
- YufengLJunYCompare the categories and extents of toxic and side-effect of time chemothrapy and routine chemothrapyFront Med2011121138140
- TaharaYOtsukaMFuseYHiraoAShibataSRefeeding after fasting elicits insulin-dependent regulation of Per2 and REV-ERBα with shifts in the liver clockJ Biol Rhythms201126323024021628550
- LéviFFilipskiEIurisciILiXMInnominatoPCross-talks between circadian timing system and cell division cycle determine cancer biology and therapeuticsCold Spring Harb Symp Quant Biol200772146547518419306
- TsimakouridzeEVAlibhaiFJMartinoTATherapeutic applications of circadian rhythms for the cardiovascular systemFront Pharmacol201567725941487
- RoennebergTDaanSMerrowMThe art of entrainmentJ Biol Rhythms200318318319412828276
- ZhangYHZhaoGFYinKFThe expression and clinical significance of β-galactose lectin 3 and clock genes Per2 in non-small cell lung cancerChinese J Heal Lab Tech2014241826922694
- YangXWoodPAOhEYDu-QuitonJAnsellCMHrusheskyWJDown regulation of circadian clock gene period 2 accelerates breast cancer growth by altering its daily growth rhythmBreast Cancer Res Treat2009117242343118651214
- HuJFuSPengQPaclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: in vitro and in vivo evaluationInt J Pharm20175161–231332227884713
- ParkCWBakYKimMJThe novel small molecule STK899704 promotes senescence of the human A549 NSCLC cells by inducing DNA damage responses and cell cycle arrestFront Pharmacol2018916329713275
- GadgeelSMPersonalized therapy of non-small cell lung cancer (NSCLC)Adv Exp Med Biol2016890320326703806
- HopeWWBoltonWDKalbaughCABlackhurstDWStephensonJETaylorSMLung cancer resection in octogenarians: a reasonable approach for our aging populationAm Surg20077312217249451
- FringsSNew molecular targeted therapeutic drugs clinical results of bevacizumab in non-small cell lung cancer (NSCLC)Haigan2006463277281
- AbbasiSBadheebAPrognostic factors in advanced non-small-cell lung cancer patients: patient characteristics and type of chemotherapyLung Cancer Int20112011414
- HuangCYJuDTChangCFMuralidhar ReddyPVelmuruganBKA review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancerBiomedicine2017742329130448
- ChenKShiWAutophagy regulates resistance of non-small cell lung cancer cells to paclitaxelTumor Biol20163781053910544
- CoynePJWanWDodsonPSwaineyCSmithTJA trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathyJ Pain Palliat Care Pharmacother201327435936424143893
- WangTHWangHSSoongYKPaclitaxel-induced cell death: Where the cell cycle and apoptosis come togetherCancer200088112619262810861441
- ChangYFLiLLWuCWPaclitaxel-induced apoptosis in human gastric carcinoma cell linesCancer199677114188630921
- Morales-CanoDCalviñoERubioVApoptosis induced by paclitaxel via Bcl-2, BAX and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibitionExp Toxicol Pathol2013657–81101110823735541
- Salah-EldinAEInoueSTsukamotoSAoiHTsudaMAn association of Bcl-2 phosphorylation and Bax localization with their functions after hyperthermia and paclitaxel treatmentInt J Cancer20031031536012455053
- YangXWoodPAAnsellCMThe circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of dayChronobiol Int20092671323133919916834
- ZhaoNYangKYangGAberrant expression of clock gene Period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinomaPLoS One201382e5589423405233
- XuYTohKLJonesCRShinJYFuYHPtácekLJModeling of a human circadian mutation yields insights into clock regulation by PER2Cell20071281597017218255
- SuXChenDYangKThe circadian clock gene PER2 plays an important role in tumor suppression through regulating tumor-associated genes in human oral squamous cell carcinomaOncol Rep201738147248028535015
- ChenSTChooKBHouMFYehKTKuoSJChangJGDeregulated expression of the PER1, PER2 and PER3 genes in breast cancersCarcinogen200526712411246
- WinterSLBosnoyan-CollinsLPinnaduwageDAndrulisILExpression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumorsNeoplasia200791079780017971899